Cargando…
The significance of different formulations of aerosolized colistin
Autores principales: | Michalopoulos, Argyris, Kasiakou, Sofia K, Falagas, Matthew E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1269429/ https://www.ncbi.nlm.nih.gov/pubmed/16137394 http://dx.doi.org/10.1186/cc3506 |
Ejemplares similares
-
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
por: Michalopoulos, Argyris, et al.
Publicado: (2005) -
Toxicity after prolonged (more than four weeks) administration of intravenous colistin
por: Falagas, Matthew E, et al.
Publicado: (2005) -
Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients
por: Michalopoulos, Argyris S, et al.
Publicado: (2011) -
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria
por: Falagas, Matthew E, et al.
Publicado: (2005) -
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
por: Falagas, Matthew E, et al.
Publicado: (2006)